Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 20;12(10):6060-6067.
doi: 10.1021/acscatal.2c01442. Epub 2022 May 6.

Photocatalytic Late-Stage Functionalization of Sulfonamides via Sulfonyl Radical Intermediates

Affiliations

Photocatalytic Late-Stage Functionalization of Sulfonamides via Sulfonyl Radical Intermediates

Michael J Tilby et al. ACS Catal. .

Abstract

A plethora of drug molecules and agrochemicals contain the sulfonamide functional group. However, sulfonamides are seldom viewed as synthetically useful functional groups. To confront this limitation, a late-stage functionalization strategy is described, which allows sulfonamides to be converted to pivotal sulfonyl radical intermediates. This methodology exploits a metal-free photocatalytic approach to access radical chemistry, which is harnessed by combining pharmaceutically relevant sulfonamides with an assortment of alkene fragments. Additionally, the sulfinate anion can be readily obtained, further broadening the options for sulfonamide functionalization. Mechanistic studies suggest that energy-transfer catalysis (EnT) is in operation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Late-stage functionalization of sulfonamides via nucleophilic,, electrophilic, and neutral reactive intermediates.
Figure 2
Figure 2
Photocatalyzed sulfinate salt formation and telescoped reaction from a primary sulfonamide. aReaction conditions: (1) p-CF3-benzyl bromide (1.5 equiv), TBAB (20 mol %), 100 °C, 24 h; (2) NFSI (1.5 equiv), K2CO3 (1.1 equiv), solvent switch to THF/H2O (10:1, 0.2 M), rt., 12 h; (3) acidify using 2 M aq. H3PO4, extract (Na2CO3). bReaction conditions: step (i) sulfonamide 9 (1.0 equiv), p-anisaldehyde (1.0 equiv), Amberlyst 15 (5 mg/mmol), PhMe (0.1 M), Dean-Stark, 12 h; step (iii) MVK (2.5 equiv), 5CzBN (0.5 mol %), TMS3Si-H (1.5 equiv), PhMe (0.05 M), blue LEDs, 15 °C, 4 h.
Figure 3
Figure 3
Mechanistic investigations. (A) Absorption spectra of 2a in toluene and emission spectra of 5CzBN in toluene using excitation at 400 nm. (B) Stern–Volmer quenching of 5CzBN in toluene using excitation at 400 nm. (C) Further screening of photocatalysts using a 0.1 mmol scale with MVK (2.5 equiv), TMS3Si-H (1.5 equiv), PhMe (0.05 M), blue LEDs, 15 °C, 4 h. (D) Control reactions using a 0.1 mmol scale with MVK (2.5 equiv), 5CzBN (0.5 mol %), TMS3Si-H (1.5 equiv), PhMe (0.05 M), blue LEDs, 15 °C, 4 h, or 3-butenylbenzene (2.5 equiv), 5CzBN (1 mol %), p-fluorothiophenol (2.2 equiv), DCE (0.1 M), blue LEDs, 15 °C, 4 h. With all potentials and triplet energies measured in MeCN. (E) Proposed catalytic cycle.

Similar articles

Cited by

References

    1. Lesch J. E.The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine; Oxford University Press: Oxford, 2007.
    1. McGrath N. A.; Brichacek M.; Njardarson J. T. A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives. J. Chem. Ed. 2010, 87, 1348–1349. 10.1021/ed1003806. - DOI
    1. Białk-Bielińska A.; Stolte S.; Matzke M.; Fabiańska A.; Maszkowska J.; Kołodziejska M.; Liberek B.; Stepnowski P.; Kumirska J. Hydrolysis of sulphonamides in aqueous solutions. J. Hazard. Mater. 2012, 221-222, 264–274. 10.1016/j.jhazmat.2012.04.044. - DOI - PubMed
    1. Shoaib Ahmad Shah S.; Rivera G.; Ashfaq M. Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents. Mini-Rev. Med. Chem. 2013, 13, 70–86. 10.2174/138955713804484749. - DOI - PubMed
    1. Fier P. S.; Maloney K. M. NHC-Catalyzed Deamination of Primary Sulfonamides: A Platform for Late-Stage Functionalization. J. Am. Chem. Soc. 2019, 141, 1441–1445. 10.1021/jacs.8b11800. - DOI - PubMed